logo conference-reports

Conference Reports

Educational service by logo MSD Oncology

ASCO-SITC 2019—High-dose NK cell infusions show benefit in myeloid malignancies

Phase 2 data show antitumor, antiviral activity with multiple infusions after haploidentical SCT.